Key Takeaway: Cardiol Therapeutics Inc. has announced details for its upcoming Annual General and Special Meeting scheduled for June 26, 2024. The record date for notice and voting is set for May 13, 2024. The meeting will involve Class A Common shares, and the information has been filed in accordance with securities regulations via Odyssey Trust Company as the issuer's agent.
Market Sentiment Analysis
Full Press Release Details
To All Applicable Exchanges and Securities Administrators
Subject: Cardiol Therapeutics Inc. (the "Issuer")
Notice of Meeting and Record Date
We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:
Meeting Type:
Annual General and Special Meeting
Meeting Date:
June 26, 2024
Record Date for Notice of Meeting:
May 13, 2024
Record Date for Voting (if applicable):
May 13, 2024
Beneficial Ownership Determination Date:
May 13, 2024
Class of Securities Entitled to Vote:
Class A Common
ISIN:
CA14161Y2006
Issuer sending proxy materials directly to NOBOs:
No
Issuer paying for delivery to OBOs:
Yes
Notice and Access for Beneficial Holders:
Yes
Beneficial Holders Stratification Criteria:
Not Applicable
Notice and Access for Registered Holders:
Yes
Registered Holders Stratification Criteria:
Not Applicable
In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.
Odyssey Trust Company
as agent for Cardiol Therapeutics Inc.
Frequently Asked Questions
What is the date of Cardiol Therapeutics' annual meeting?
The annual meeting is scheduled for June 26, 2024.
When is the record date for voting?
The record date for voting is May 13, 2024.
What class of securities can vote?
Class A Common securities are entitled to vote.
Who is sending proxy materials?
The issuer is not sending proxy materials directly to NOBOs.
Is notice and access available for registered holders?
Yes, notice and access are available for registered holders.